Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction

Registry ID
NCT07764588
Source registry
NCT
Status
RECRUITING
Study type
OBSERVATIONAL
Sponsor
Shanghai 10th People's Hospital
Enrollment
50
Start date
2026-01-01
Completion date
2026-12-31
Last update
2026-08-14

Conditions

Summary

To determine the relationship of the phenotypes of neutrophils and monocytes with early fibrotic repair after acute myocardial infarction.

Detailed description

This study will enroll 50 patients with ST-segment elevation myocardial infarction (STEMI). Peripheral blood will be collected from these patients for immune cell subset analysis, serum cytokine evaluation, and neutrophil sorting for transcriptome sequencing. At 1 week after admission, cardiac magnetic resonance (CMR) will be performed to evaluate the myocardial salvage index, area of late gadolinium enhancement (LGE), microvascular obstruction (MVO), extracellular volume (ECV), and left ventricular ejection fraction (LVEF).

Inclusion criteria

Inclusion Criteria: \---- Age \> 18 and ≤ 80 years old \- Patients with acute STEMI within 12 hours of symptom onset who are planned to receive PPCI

Exclusion criteria

Exclusion Criteria: * Prior revascularization * Known allergy to gadopentetate dimeglumine contrast agent * Pregnancy or planned pregnancy within the next 6 months * Life expectancy \< 1 year * Metallic implants or claustrophobia that precluded MRI * Severe COPD or inability to hold breath for MRI * Severe hepatic or renal dysfunction (ALT \> 5×ULN or eGFR \< 15 mL/min/1.73 m²)

Primary outcomes

[{"measure":"Major cardiac adverse outcome","timeFrame":"At 12 months after enrollment"}]

Locations

Related clinical trials

View on source registry